RankAlpha logo
Back to Rankings

RNA

Atrium TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The constructive case is that Atrium launched with about $270 million in cash, a stated runway through clinical proof-of-concept, two lead cardiomyopathy assets, and ongoing collaboration optionality including up to $1.5 billion of potential R&D milestones from existing BMS and Lilly collaborations [#PR-2026-02-27] [#IR-2026-02].
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Collaboration economics are milestone-based and contingent; the April payment is positive, but future BMS or Lilly value realization is not assured [#PR-2026-04-23] [#IR-2026-02].
Momentum
18
Value
59
Sentiment
49
Setup hits (3d)
— · Net —
AI TargetsBase $12.00 · Bull $20.00 · Bear $7.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-07 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net —
Target $36.75
Why
Momentum18 · Δ7d -11.1
Value59 · Δ7d -0.1
Sentiment49 · Δ7d -1.1
So what
Weak posture. Prioritize risk control and patience.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Value · See fundamentals
Momentum
18
26% active weight
Current posture
7d trendImproving
Δ7d
-11.1
Δ21d
+12.3
Value
59
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.0
Sentiment
49
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.1
Δ21d
+6.0
Why this grade

Composite grade D. Momentum 18.4 / Value 58.7 / Sentiment 48.8

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$207.83M
Beta
0.93
Shares Out
17.11M
P/E (TTM) · Derived
-4.2
P/S (TTM)
520.38
P/FCF (TTM) · Derived
-2.68
Rev YoY
+1148.3%
EPS YoY
+123.3%
Gross Margin
-
Op Margin
-2934.9%
Net Debt
$3.67M
Current Ratio
13.04
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology